Document Details
Form
Filing Date
Feb 15, 2024
Document Date
Feb 13, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Celldex Therapeutics
Issuer
CELLDEX THERAPEUTICS, INC.